Beckman Coulter’s Power Express Automated Sample Processing System Receives FDA Clearance

Beckman Coulter has received U.S. Food and Drug Administration (FDA) 510(k) clearance on its Power Express high-speed automated sample processing system.

Designed to meet the needs of the most demanding laboratories, the Power Express processes samples for all core disciplines – chemistry, immunoassay, haematology and coagulation. The Power Express provides the enhanced benefit of connected automation by combining Beckman Coulter’s industry-leading AU clinical chemistry system; the UniCel DxI 800 immunoassay system for high-throughput immunochemistry analysis; third-party connection capabilities, including coagulation; and plans to include Beckman Coulter haematology solutions this year

Follow Evolution Global Talent Attraction on Twitter, Facebook and LinkedIN to keep up-to-date with news and trends from the biotechnology, biosciences, medical device, IT and Intellectual Property industries.